Business Description
CHO Pharma Inc
ISIN : TW0006586001
Description
CHO Pharma Inc is a biopharmaceutical company mainly focused on the development and commercialization of innovative products based on the proprietary glycan engineering technologies. It offers antibodies, such as CHO-H01, CHO-H02, CHO-A04 for cancer; CHO-H03, an antibody for autoimmune disease; CHO-S05 dual-effect anti-flu drugs; and CHO-V06 glycan-based vaccines and drugs.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 69.25 | |||||
| Equity-to-Asset | 0.96 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.16 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -1.5 | |||||
| 3-Year EPS without NRI Growth Rate | 0.4 | |||||
| 3-Year FCF Growth Rate | -1.3 | |||||
| 3-Year Book Growth Rate | 9.2 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.65 | |||||
| 9-Day RSI | 44.24 | |||||
| 14-Day RSI | 45.72 | |||||
| 6-1 Month Momentum % | -24.41 | |||||
| 12-1 Month Momentum % | -24.85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 23.43 | |||||
| Quick Ratio | 23.43 | |||||
| Cash Ratio | 23 | |||||
| Days Sales Outstanding | 141.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.2 | |||||
| Shareholder Yield % | -0.24 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 50.65 | |||||
| Operating Margin % | -21424.77 | |||||
| Net Margin % | -23590.94 | |||||
| FCF Margin % | -23132.16 | |||||
| ROE % | -10.74 | |||||
| ROA % | -10.17 | |||||
| ROIC % | -48.03 | |||||
| ROC (Joel Greenblatt) % | -1170.28 | |||||
| ROCE % | -10.67 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 10920 | |||||
| PB Ratio | 4.06 | |||||
| Price-to-Tangible-Book | 4.55 | |||||
| EV-to-EBIT | -34.12 | |||||
| EV-to-EBITDA | -38.09 | |||||
| EV-to-Revenue | 8037.21 | |||||
| EV-to-FCF | -35.51 | |||||
| Price-to-Net-Current-Asset-Value | 4.64 | |||||
| Price-to-Net-Cash | 4.74 | |||||
| Earnings Yield (Greenblatt) % | -2.93 | |||||
| FCF Yield % | -2.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CHO Pharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1.082 | ||
| EPS (TTM) (NT$) | -1.25 | ||
| Beta | 0.48 | ||
| Volatility % | 33.3 | ||
| 14-Day RSI | 45.72 | ||
| 14-Day ATR (NT$) | 2.114975 | ||
| 20-Day SMA (NT$) | 53.17 | ||
| 12-1 Month Momentum % | -24.85 | ||
| 52-Week Range (NT$) | 49 - 72.3 | ||
| Shares Outstanding (Mil) | 214.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CHO Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CHO Pharma Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
CHO Pharma Inc Frequently Asked Questions
What is CHO Pharma Inc(ROCO:6586)'s stock price today?
The current price of ROCO:6586 is NT$52.10. The 52 week high of ROCO:6586 is NT$72.30 and 52 week low is NT$49.00.
When is next earnings date of CHO Pharma Inc(ROCO:6586)?
The next earnings date of CHO Pharma Inc(ROCO:6586) is .
Does CHO Pharma Inc(ROCO:6586) pay dividends? If so, how much?
CHO Pharma Inc(ROCO:6586) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers